GENTERA:BMVGentera SAB de CV Analysis
Data as of 2026-06-21 - not real-time
MX$38.35
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Gentera trades well below its 20‑day, 50‑day and 200‑day simple moving averages, indicating a bearish technical backdrop. The MACD histogram is negative and the signal line is bearish, reinforcing short‑term downside pressure. However, the stock’s price‑to‑earnings multiple is markedly lower than the industry average, and the dividend yield sits comfortably above 4%, with a modest payout ratio that suggests sustainability.
Revenue is growing at double‑digit rates and operating margins are robust, while the balance sheet shows ample cash relative to debt, resulting in a low beta and an “extreme greed” sentiment in the market. These fundamentals, combined with an upside potential of over 40% based on analyst targets, make the equity attractive from a valuation perspective despite the current bearish price action.
Revenue is growing at double‑digit rates and operating margins are robust, while the balance sheet shows ample cash relative to debt, resulting in a low beta and an “extreme greed” sentiment in the market. These fundamentals, combined with an upside potential of over 40% based on analyst targets, make the equity attractive from a valuation perspective despite the current bearish price action.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish technical indicators (price below SMAs, negative MACD)
- Strong dividend yield providing downside cushion
- Limited upside until support level is tested
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued valuation relative to peers
- Solid revenue growth and high operating margins
- Analyst target price indicating >40% upside
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Sustainable dividend policy with low payout ratio
- Stable cash flow and strong balance sheet
- Low beta suggesting resilience in diversified portfolios
Key Metrics & Analysis
Financial Health
Revenue Growth11.20%
Profit Margin22.79%
P/E Ratio6.3
ROE23.86%
ROA7.65%
P/B Ratio1.6
Op. Cash FlowMX$2.3B
Industry P/E16.9
Technical Analysis
TrendBearish
RSI43.4
SupportMX$35.55
ResistanceMX$45.01
MA 20MX$40.25
MA 50MX$43.10
MA 200MX$46.18
MACDBearish
VolumeIncreasing
Fear & Greed Index91.46
Valuation
Target PriceMX$55.29
Upside/Downside44.16%
GradeUndervalued
TypeBlend
Dividend Yield4.70%
Risk Assessment
Beta0.19
Volatility47.21%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.